La recherche

Tumour immunology and immunotherapy

Group 1 of the Inserm (National Institute of Health and Medical Research) UMR 1015 research unit, « Tumour immunology and immunotherapy of cancer », is under the direction of Professor Laurence Zitvogel. Between 2015 and 2018 it will be exploring three lines of research:
- Gut microbiota and pro- or anti-tumour inflammatory/immunological activity, by measuring the effect of specific therapies on their regulation,

Characterisation of gynaecological cancers - Lab members

back to job offer list

back to clinical trials

Lab members

Clara Nahmias (DR CNRS, HDR)
Adam Telerman (MD, DRCN CNRS)
Olivia Fromigué (CRCN-HDR INSERM)
Anna Rocca (CRCN CNRS)
Robert Amson (MD, researcher)
Sylvie Rodrigues-Ferreira (researcher, Innovarion)
Catherine Genestie (Pathologist, GRCC)
Magali Lacroix-Triki (MD, PhD, Pathologist)
Alexandra Leary (MD, PhD, GRCC)
Etienne Rouleau (MD, PhD, GRCC)
Inés Vaz-Luis (MD, PhD)
Jean-Charles Ahomadegbe (MCU Amiens, HDR)
Tony Sourisseau (Engineer, GRCC)

Characterisation of gynaecological cancers - Publications

back to job offer list

back to clinical trials

Major publications

Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Dien AT, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Dogan S, Verret B,Chaffanet M, Bachelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron T, Le Tourneau C, André F. Genomic characterization of metastatic breast cancers. Nature. 2019

Molecular caracterization of breast and gynecologic cancers

back to job offer list

back to clinical trials

Molecular caracterization of breast and gynecologic cancers

This team belongs to the UMR 981 - Molecular predictors and new targets in oncology

The haematopoietic niche - Current research

back to job offer list

back to clinical trials

The haematopoietic niche group

The hematopoietic niche - Lab members

back to job offer list

back to clinical trials

Lab members

Fawzia Louache, DR2 Inserm, Group leader
Virginie Joulin, DR2 Inserm,
Monika Wittner, CR1 CNRS,
Paul Coppo, PU-PH Paris 6,
Yanyan Zhang, Post-doc
Mallorie Mangean, PhD student
HE Liang, PhD student
Eric Grignano, Master 2

The hematopoietic niche - Publications

back to job offer list

back to clinical trials

Recent publications

Bouchekioua A, Scourzic L, de Wever O, Zhang Y, Cervera P, Aline-Fardin A, Mercher T, Gaulard P, Nyga R, Jeziorowska D, Douay L, Vainchenker W, Louache F, Gespach C, Solary E, Coppo P. JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma. Leukemia. 2014;28(2):338-48.